{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:37Z","timestamp":1762867897840,"version":"3.37.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"crossref","award":["HHSO100200600017C"],"award-info":[{"award-number":["HHSO100200600017C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222670","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T17:26:09Z","timestamp":1568741169000},"page":"e0222670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-3964","authenticated-orcid":true,"given":"Douglas","family":"Barker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen T.","family":"Gillum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Niemuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-5952","authenticated-orcid":true,"given":"Shantha","family":"Kodihalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,9,17]]},"reference":[{"key":"pone.0222670.ref001","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"SS Arnon","year":"2001","journal-title":"JAMA"},{"key":"pone.0222670.ref002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology pharmacology and toxicology.","volume":"69","author":"M Pirazzini","year":"2017","journal-title":"Pharmacological reviews"},{"key":"pone.0222670.ref003","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4161\/hv.9420","article-title":"Botulinum neurotoxin vaccines: Past history and recent developments","volume":"5","author":"JM Rusnak","year":"2009","journal-title":"Hum Vaccin"},{"key":"pone.0222670.ref004","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/B978-0-12-369408-9.00046-9","volume-title":"Vaccines for Biodefense and Emerging and Neglected Diseases","author":"LL Simpson","year":"2009"},{"year":"2019","author":"Centers for Disease Control and Prevention (CDC)","key":"pone.0222670.ref005"},{"key":"pone.0222670.ref006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/oxfordjournals.aje.a121239","article-title":"Botulism in the United States 1899\u20131969","volume":"93","author":"EJ Gangarosa","year":"1971","journal-title":"Am J Epidemiol"},{"key":"pone.0222670.ref007","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review","volume":"129","author":"RL Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0222670.ref008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DMP.0b013e318158c5fd","article-title":"Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities","volume":"1","author":"ZF Dembek","year":"2007","journal-title":"Disaster Medicine and Public Health Preparedness"},{"key":"pone.0222670.ref009","first-page":"580","article-title":"Existence of type D botulism in man","volume":"142","author":"J Demarchi","year":"1958","journal-title":"Bull Acad Natl Med"},{"key":"pone.0222670.ref010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9343(67)90020-4","article-title":"I, Schaffner W, Rogers DE. Type B botulism in man","volume":"42","author":"MG Koenig","year":"1967","journal-title":"Am J Med"},{"key":"pone.0222670.ref011","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2105\/AJPH.71.3.266","article-title":"Patient recovery from type A botulism: morbidity assessment following a large outbreak","volume":"71","author":"JM Mann","year":"1981","journal-title":"Am J Public Health"},{"key":"pone.0222670.ref012","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1128\/JCM.29.11.2618-2620.1991","article-title":"Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult","volume":"29","author":"LM McCroskey","year":"1991","journal-title":"J Clin Microbiol"},{"key":"pone.0222670.ref013","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/0140-6736(90)93157-K","article-title":"Infant botulism due to Clostridium botulinum type C toxin","volume":"336","author":"K Oguma","year":"1990","journal-title":"Lancet"},{"key":"pone.0222670.ref014","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.aje.a113111","article-title":"Restaurant-associated type A botulism: transmission by potato salad","volume":"113","author":"JE Seals","year":"1981","journal-title":"Am J Epidemiol"},{"key":"pone.0222670.ref015","first-page":"1167","article-title":"Clinical infectious diseases: an official publication of the","volume":"41","author":"Sobel J. Botulism","year":"2005","journal-title":"Infectious Diseases Society of America"},{"key":"pone.0222670.ref016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/infdis\/143.1.22","article-title":"Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths","volume":"143","author":"O Sonnabend","year":"1981","journal-title":"J Infect Dis"},{"key":"pone.0222670.ref017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/161.2.340","article-title":"An international outbreak of type E botulism due to uneviscerated fish","volume":"161","author":"EE Telzak","year":"1990","journal-title":"J Infect Dis"},{"key":"pone.0222670.ref018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/oxfordjournals.aje.a112599","article-title":"Botulism type B: epidemiologic aspects of an extensive outbreak","volume":"108","author":"W Terranova","year":"1978","journal-title":"Am J Epidemiol"},{"key":"pone.0222670.ref019","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-125-7-199610010-00004","article-title":"An outbreak of type A botulism associated with a commercial cheese sauce","volume":"125","author":"JM Townes","year":"1996","journal-title":"Ann Intern Med"},{"key":"pone.0222670.ref020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/167.2.451","article-title":"A massive outbreak of type E botulism associated with traditional salted fish in Cairo","volume":"167","author":"JT Weber","year":"1993","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0222670.ref021","doi-asserted-by":"crossref","first-page":"e0209019","DOI":"10.1371\/journal.pone.0209019","article-title":"Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model.","volume":"14","author":"A Emanuel","year":"2018","journal-title":"PLoS One"},{"key":"pone.0222670.ref022","first-page":"113","volume-title":"Botulism: Proceedings of a Symposium","author":"MA Cardella","year":"1964"},{"issue":"Suppl 1","key":"pone.0222670.ref023","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9","article-title":"J. Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model","volume":"19","author":"TR Gelzleichter","year":"1999","journal-title":"J Appl Toxicol"},{"key":"pone.0222670.ref024","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/clinids\/1.4.689","article-title":"Human-derived immune globulins for the treatment of botulism","volume":"1","author":"JF Metzger","year":"1979","journal-title":"Rev Infect Dis"},{"key":"pone.0222670.ref025","doi-asserted-by":"crossref","first-page":"e0186892","DOI":"10.1371\/journal.pone.0186892","article-title":"Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques","volume":"12","author":"S Kodihalli","year":"2017","journal-title":"PLoS One"},{"year":"1996","author":"National Research Council (US) Institute for Laboratory Animal Research","key":"pone.0222670.ref026"},{"key":"pone.0222670.ref027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"LL Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"unstructured":"FDA. Guidance for Industry Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER); 2005. Available from: https:\/\/www.fda.gov\/media\/72309\/download. Cited 20 June 2019.","key":"pone.0222670.ref028"},{"unstructured":"FDA. Product Development Under the Animal Rule Guidance for Industry. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER); 2015. Available from: https:\/\/www.fda.gov\/media\/88625\/download. Cited 20 June 2019.","key":"pone.0222670.ref029"},{"key":"pone.0222670.ref030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1128\/AEM.34.6.843-848.1977","article-title":"Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin","volume":"34","author":"AS Ciccarelli","year":"1977","journal-title":"Appl Environ Microbiol"},{"key":"pone.0222670.ref031","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/JCM.40.6.2260-2262.2002","article-title":"Botulism due to Clostridium baratii type F toxin","volume":"40","author":"SM Harvey","year":"2002","journal-title":"J Clin Microbiol"},{"key":"pone.0222670.ref032","first-page":"643","volume-title":"Medical Aspects of Clinical and Biological Warfare","author":"JL Middlebrook","year":"1997"},{"key":"pone.0222670.ref033","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/508176","article-title":"An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure","volume":"43","author":"S Kongsaengdao","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pone.0222670.ref034","doi-asserted-by":"crossref","first-page":"802","DOI":"10.15585\/mmwr.mm6429a6","article-title":"Large Outbreak of Botulism Associated with a Church Potluck Meal\u2014Ohio 2015. MMWR.","volume":"64","author":"CL McCarty","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"pone.0222670.ref035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type A foodborne botulism","volume":"76","author":"CO Tacket","year":"1984","journal-title":"Am J Med"},{"key":"pone.0222670.ref036","article-title":"Safety and clinical outcomes of an equine-derived heptavalent botulinum antitoxin treatment for confirmed or suspected botulism in the United States","author":"JS Richardson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pone.0222670.ref037","first-page":"473","article-title":"Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak","volume":"48","author":"AP Ball","year":"1979","journal-title":"Q J Med"},{"key":"pone.0222670.ref038","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(89)91822-9","article-title":"Slow recovery from severe foodborne botulism","volume":"2","author":"JG Colebatch","year":"1989","journal-title":"Lancet"},{"key":"pone.0222670.ref039","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.2174\/1568026614666141022093350","article-title":"Recent advances in botulinum neurotoxin inhibitor development","volume":"14","author":"E Kiris","year":"2014","journal-title":"Curr Top Med Chem"},{"issue":"Suppl 1","key":"pone.0222670.ref040","first-page":"S57","article-title":"Safety and improved clinical outcomes in patients treated with new equine-derived heptavalent botulinum antitoxin","volume":"66","author":"PA Yu","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pone.0222670.ref041","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jps.23076","article-title":"Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements","volume":"101","author":"W Cheng","year":"2012","journal-title":"J Pharm Sci"},{"issue":"9","key":"pone.0222670.ref042","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/toxins8090257","article-title":"Neutralization of botulinum neurotoxin type E by a humanized antibody","volume":"8","author":"Y Derman","year":"2016","journal-title":"Toxins"},{"key":"pone.0222670.ref043","doi-asserted-by":"crossref","first-page":"e0174187","DOI":"10.1371\/journal.pone.0174187","article-title":"A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes","volume":"12","author":"Y Fan","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"pone.0222670.ref044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/toxins10030105","article-title":"A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype E subtypes","volume":"10","author":"C Garcia-Rodriguez","year":"2018","journal-title":"Toxins"},{"key":"pone.0222670.ref045","doi-asserted-by":"crossref","first-page":"e3023","DOI":"10.1371\/journal.pone.0003023","article-title":"Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain","volume":"3","author":"SP Adekar","year":"2008","journal-title":"PLoS One"},{"key":"pone.0222670.ref046","doi-asserted-by":"crossref","first-page":"e0197011","DOI":"10.1371\/journal.pone.0197011","article-title":"An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E.","volume":"13","author":"M Li","year":"2018","journal-title":"PLoS One"},{"key":"pone.0222670.ref047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/hyb.2008.0066","article-title":"Monoclonal antibody and siRNAs for topoisomerase I suppress telomerase activity","volume":"28","author":"H Takahashi","year":"2005","journal-title":"Hybridoma"},{"key":"pone.0222670.ref048","first-page":"219","article-title":"Structure activity and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"MZ Atassi","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"pone.0222670.ref049","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"2nd, Lou J, Marks JD. Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"LW Cheng","year":"2009","journal-title":"Infect Immun"},{"key":"pone.0222670.ref050","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1124\/jpet.106.104661","article-title":"An initial assessment of the systemic pharmacokinetics of botulinum toxin","volume":"318","author":"E Ravichandran","year":"2006","journal-title":"J Pharmacol Exp Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T03:31:22Z","timestamp":1611199882000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222670"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Gillet","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,9,17]]}}}